DWA
WVE icon

Dorsey Wright & Associates’s Wave Life Sciences WVE Stock Holding History

Dorsey Wright & Associates’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,400
Closed -$30.8K – 362
2022
Q4 		$30.8K Buy
+4,400
New +$20.3K 0.01% 175

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dorsey Wright & Associates's WVE Position: Q1 2023 in Review

Dorsey Wright & Associates sold out of Wave Life Sciences (WVE) in Q1 2023, closing a stake of 4,400 shares — an estimated $30.8K sold.

Dorsey Wright & Associates first reported a position in WVE in Q4 2022 and held it in 1 quarter. The position peaked at $30.8K in Q4 2022. 72 funds tracked by Wall St. Rank hold WVE as of Q1 2023.

  • Dorsey Wright & Associates reported no remaining Wave Life Sciences position as of Q1 2023 after selling out during the quarter.
  • Dorsey Wright & Associates sold 4,400 Wave Life Sciences shares in Q1 2023, an estimated $30.8K.
  • Dorsey Wright & Associates first reported a position in Wave Life Sciences in Q4 2022 and held it in 1 quarter.
  • Dorsey Wright & Associates's Wave Life Sciences position peaked at $30.8K in Q4 2022.
  • 72 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2023.

Based on Dorsey Wright & Associates's 13F filing for Q1 2023, filed 20 Apr 2023.